Skip to content

Uremic Toxins, Cardiovascular Effects and Physical Activity in Intensive Hemodialysis

Uremic Toxins, Cardiovascular Effects and Physical Activity in Intensive Hemodialysis - Long-term Effects of Intensive Hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39123
Enrollment
140
Registered
2011-04-27
Start date
2012-08-31
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage renal disease

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Incident and prevalent conventional hemodialysis (CHD), intensive HD [short daily hemodialysis (SDHD), nocturnal hemodialysis (NHD) and home nocturnal hemodialysis (HNHD)] and peritoneal dialysis (PD) patients -Different patient groups (CHD, intensive HD and PD) will be matched according to transplantation candidature en Charlson Comorbidity Index -Standard renal diet (80 g of protein per day) -Age > 18 years -Informed consent

Exclusion criteria

Exclusion criteria: -Charlson risk index of 5 or higher -Chronic antibiotic use and colectomy because of interference with uremic toxin formation and degradation -Withdrawal of consent -For bio-impedance measurements: presence of ICD or pacemaker. There are no restrictions for other measurements in these patients.

Design outcomes

Primary

MeasureTime frame
-Pulse wave velocity

Secondary

MeasureTime frame
-Levels of uremic toxins -Physical activity

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)